Three new pan-European biological science research facilities were announced earlier this month as part of the revised European Strategy Forum on Research Infrastructures. France’s Infrastructure for Analysis and Experimentation on Ecosystems (ANAEE), the UK’s Infrastructure for Systems Biology-Europe (ISBE), and France and Germany’s EU Microbial Resource Research Infrastructure (MIRRI) will be funded by the EU […]
Chile’s health minister intends to submit a plan for a national medicines agency, the Agencia Nacional de Medicamentos (Anamed), to the country’s parliament. Anamed would preside over drug regulations, a task that currently belongs to the National Institute of Public Health, and would create and enforce bioequivalence requirements. Currently, local drugmakers can manufacture and market […]
Although Australia’s 2012 budget, revealed May 10, has been slashed by AUD 22 billion ($24 billion), funding for some research agencies has not. The budgets of the National Health and Medical Research Council, and the Australian Research Council will remain at AUD 850 million and AUD 845 million, respectively. Regional universities will receive AUD 500 […]
In April, KPMG surveyed 550 financial executives at energy companies. Among respondents, 67% believe that crude oil prices will top $111 per barrel this year. For 55% of respondents, regulatory issues will be their primary challenge this year, and for 43%, they will be the biggest factor affecting capital spending decisions. Sixty-seven percent expect capital […]
For 47% of the nearly 400 food and beverage processors who responded to the annual Food Processing R&D survey, the most important goal for their R&D efforts this year is new product development. Existing product improvement is most important for 17%, and for 14%, cost control is the top priority. Asked to rank concerns as […]
In 2010, Pharmaceutical Research and Manufacturers of America (PhRMA) members spending on R&D grew 6.5% to $49.4 billion. R&D spending by the total biopharmaceutical industry grew an estimated 2.3% to $67.4 billion. PhRMA members’ domestic R&D spending rose 5.7% to $37,371.0 million, while foreign spending increased 8.7% to $12,047.4 million. As a percentage of sales, […]
US equity markets trended lower in May following disappointing economic data, including weaker-than-expected manufacturing and durable goods orders. Other economic threats, such as inflation, unemployment and the European sovereign debt crisis, further soured investor sentiment. For the month, the Dow Jones Industrial Average, S&P 500 and NASDAQ fell 1.9%, 1.4% and 1.3%, respectively. Despite some […]
In the first quarter of the new year, instrument and laboratory product companies faced some challenges, including the aftereffects of the Japanese disaster and, in some cases, tough year-over-year comparisons. Despite these difficulties, the eight businesses whose quarterly results are profiled on pages 9–11 recorded total sales growth of 16.9% in the calendar-year first quarter. […]
San Diego, CA 5/23/11—Accelrys has acquired Contur Software, a Swedish supplier of cost-effective ELNs, for $13.1 million in cash, including $0.5 million in milestone payments. “With the addition of Contur’s software solutions, Accelrys now offers cost-effective ELNs to meet the range of needs of various scientific research and development teams—from R&D organizations transitioning from paper […]
St. Louis, MO 5/23/11—Sigma-Aldrich has acquired all outstanding shares of Vetec Quimica Fina for an undisclosed amount. Based in Brazil with more than 200 employees, Vetec is a supplier of specialty chemicals for the academic and industrial markets. “In addition to localizing our supply chain, the combination of Vetec and Sigma-Aldrich allows us to broaden […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
